First in-human study of AMG 853 in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs AMG-853 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Amgen
- 05 Nov 2010 New trial record.
- 14 May 2010 Results presented at the 106th International Conference of the American Thoracic Society.
- 26 Feb 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.